SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 63 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,702,445 | -35.9% | 2,566,784 | +13.5% | 0.00% | – |
| Q2 2023 | $15,148,165 | +108.0% | 2,260,920 | +102.1% | 0.00% | – |
| Q1 2023 | $7,281,859 | -5.5% | 1,118,565 | +23.8% | 0.00% | – |
| Q4 2022 | $7,707,239 | +100.6% | 903,545 | +24.2% | 0.00% | – |
| Q3 2022 | $3,842,000 | +28.0% | 727,704 | +2.8% | 0.00% | – |
| Q2 2022 | $3,001,000 | -46.8% | 707,845 | -56.0% | 0.00% | – |
| Q1 2022 | $5,642,000 | -46.4% | 1,607,500 | +1.8% | 0.00% | – |
| Q4 2021 | $10,518,000 | -14.2% | 1,579,287 | +28.6% | 0.00% | – |
| Q3 2021 | $12,252,000 | -54.9% | 1,227,661 | +39.6% | 0.00% | -100.0% |
| Q2 2021 | $27,164,000 | -48.9% | 879,365 | -27.9% | 0.00% | -50.0% |
| Q1 2021 | $53,195,000 | +194.2% | 1,219,268 | +212.5% | 0.00% | +100.0% |
| Q4 2020 | $18,081,000 | – | 390,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $10,085,000 | 3.26% |
| K2 PRINCIPAL FUND, L.P. | 3,247,533 | $16,890,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,045,234 | $5,519,000 | 1.09% |
| Orbimed Advisors | 8,740,887 | $46,152,000 | 0.86% |
| Rubric Capital Management LP | 2,695,170 | $14,230,000 | 0.72% |
| Prosight Management, LP | 196,257 | $1,036,000 | 0.56% |
| Nantahala Capital Management | 1,249,863 | $6,599,000 | 0.43% |
| Oasis Management Co Ltd. | 317,662 | $1,677,000 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 409,463 | $2,162,000 | 0.26% |
| APOGEM CAPITAL LLC | 13,793 | $73,000 | 0.07% |